Author | Jason M. Broderick | OncLive

Author | Jason M. Broderick

Articles

FDA Grants DKN-01 Orphan Drug Status for Gastric/GEJ Cancer

June 12, 2020

Article

The FDA has granted an Orphan Drug designation to DKN-01 for the treatment of patients with gastric cancer or gastroesophageal junction cancer.

FDA Grants Berubicin Orphan Drug Status for Brain Cancer

June 11, 2020

Article

The FDA has granted an orphan drug designation to berubicin for the treatment of patients with malignant gliomas.

FDA Approves Nivolumab for Esophageal Cancer

June 11, 2020

Article

The FDA has approved nivolumab for the treatment of patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma.

Pembrolizumab Combo Falls Short in Phase 3 Frontline Urothelial Carcinoma Trial

June 10, 2020

Article

Adding pembrolizumab to chemotherapy did not lead to a statistically significant improvement in overall survival or progression-free survival in patients with advanced or metastatic urothelial carcinoma, according to findings from the phase 3 KEYNOTE-361 trial.

x